Invasive pneumococcal disease in England and Wales: Vaccination implications

Journal of Infectious Diseases

Volumn 183, Issue 2, 2001, Pages 239-246

  Sleeman, Karen ^a   Knox, Kyle ^a,b   George, Robert ^c   Miller, Elizabeth ^c   Waight, Pauline ^c   Griffiths, David ^a   Efstratiou, A ^c   Broughton, K ^c   Mayon White, Richard T ^a,c   Moxon, E R ^a   Crook, D W ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNIZATION; INFANT; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; UNITED KINGDOM; VACCINATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MICROBIAL; ENGLAND; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VACCINES, CONJUGATE; WALES;

EID: 0035863530     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/317924     Document Type: Article

References (63)

1. The burden of pneumococcal disease among adults in developed and developing countries: What is and is not known
2. Pneumococcal vaccine after 15 years of use: Another view
3. Pneumococcal vaccines: WHO position paper
4. T cell regulation of the antibody response to bacterial polysaccharide antigens: An examination of some general characteristics and their implications
5. Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide vaccines
6. Efficacy of heptavalent conjugate pneumococcal vaccine (Wyeth Lederle) in 37,000 infants and children: Impact on pneumonia, otitis media and an update on invasive disease: Results extended follow-up of The Efficacy Trial Cohort
7. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
8. Effect of heptavalent pneumococcal conjugate vaccine (PncCRM) on pneumococcal acute otitis media (AOM) by serotype
9. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine
10. Reduction of pneumococccal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid
11. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine
12. Acquisition and invasiveness of different serotypes of Streptococcus pneumoniae in young children
13. Pneumococci causing invasive disease in Britain 1982-1990
14. Epidemiology of Streptococcus pneumoniae infections at the Edinburgh City Hospital: 1980-95
15. Pneumococcal meningitis in the North East Thames Region UK: Epidemiology and molecular analysis of isolates
16. Prevalence of antibiotic resistance and serotypes in pneumococcus in England and Wales: Results of observation surveys in 1990-1995
17. Hospital admissions in children due to pneumococcal pneumonia in England and Wales
18. Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae
19. Prevalence of antibiotic resistance and serotypes in pneumococcus in England and Wales: Results of observation surveys in 1990-1995
20. Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989-94
21. Bacteraemic pneumococcal infections in southern Sweden 1981-96: Trends in incidence, mortality, age-distribution, serogroups and penicillin-resistance
22. Epidemiology of invasive pneumococcal infections in children in Finland
23. Epidemiology of invasive childhood pneumococcal infections in Israel: The Israeli Pediatric Bacteremia and Meningitis Group
24. Epidemiology of invasive pneumococcal disease in southern California: Implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial
25. The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990: Ethnic differences and opportunities for prevention
26. High incidence rates of invasive pneumococcal disease in the White Mountain Apache population
27. Active laboratory-based surveillance for invasive Streptococcus pneumoniae (pneumococcus) among Navajo people in the American Southwest, 1989-1996
28. Invasive pneumococcal disease in a pediatric population, Auckland, New Zealand
29. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998
30. Invasive pneumococcal infections: Incidence, predisposing factors, and prognosis
31. Sickle cell anemia and severe infections due to encapsulated bacteria
32. Bacteremic pneumococcal pneumonia in HIV-seropositive and HIV-seronegative adults
33. Mannose binding protein gene and susceptibility to invasive pneumococcal diseases
34. Effectiveness of pneumococcal vaccine
35. Association between FcγR11a-R131 allotype and bacteremic pneumococcal pneumonia
36. Cigarette smoking and invasive pneumococcal disease
37. Risk factors for invasive disease caused by Streptococcus pneumoniae among Alaska native children younger than two years of age
38. Risk factors for primary invasive pneumococcal disease among children in Finland
39. A study of risk factors for pneumococcal disease among children in a rural area of west Africa
40. Epidemiology of invasive Streptococcus pneumoniae infections in adults in Finland
41. Infantile meningitis in England and Wales: A two-year study
42. Neonatal meningitis: A review of routine national data 1975-1983
43. Invasive pneumococcal infection in South and West England
44. Conclusions from The WHO Multicenter Study of Serious Infections in Young Infants
45. Incidence, capsular types, and antibiotic susceptibility of invasive Streptococcus pneumoniae in Sweden
46. Serotypes and antibacterial susceptibility of pneumococci isolated from children with infections in Ankara in relation to proposed pneumococcal vaccine coverage
47. Pneumococal bacteremia in two tertiary care hospitals in Winnipeg, Canada
48. Seroepidemiology of invasive pneumococcal disease in Queensland, 1990 to 1997
49. Epidemiology of Streptococcus pneumoniae infection in Malaysia
50. Potential interventions for the prevention of childhood pneumonia: Geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children: Implications for vaccine strategies
51. An outbreak of pneumococcal pneumonia in two men's shelters
52. An outbreak of serotype 1 Streptococcus pneumoniae infection in central Australia
53. An outbreak of type 1 pneumococcal pneumonia in a men's shelter
54. Outbreaks of pneumococcal pneumonia among unvaccinated residents in chronic-care facilities: Massachussets, October 1995, Oklahoma, February 1996, and Maryland, May-Jane 1996
55. Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae